Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52


A practical model for research with learning health systems: Building and implementing effective complex case management.

Smith MA, Nordby PA, Yu M, Jaffery J.

Appl Ergon. 2020 Apr;84:103023. doi: 10.1016/j.apergo.2019.103023. Epub 2019 Dec 5.


Cox regression with survival-time-dependent missing covariate values.

Yi Y, Ye T, Yu M, Shao J.

Biometrics. 2019 Sep 24. doi: 10.1111/biom.13155. [Epub ahead of print]


Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation.

Witt JS, Jagodinsky JC, Liu Y, Yadav P, Kuczmarska-Haas A, Yu M, Maloney JD, Ritter MA, Bassetti MF, Baschnagel AM.

Am J Clin Oncol. 2019 Aug;42(8):662-667. doi: 10.1097/COC.0000000000000573.


The importance of health insurance claims data in creating learning health systems: evaluating care for high-need high-cost patients using the National Patient-Centered Clinical Research Network (PCORNet).

Smith MA, Vaughan-Sarrazin MS, Yu M, Wang X, Nordby PA, Vogeli C, Jaffery J, Metlay JP.

J Am Med Inform Assoc. 2019 Nov 1;26(11):1305-1313. doi: 10.1093/jamia/ocz097.


Xenograft-based platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Zhao SG, Yu M, Spratt DE, Chang SL, Feng FY, Kim MM, Speers CW, Carlson BL, Mladek AC, Lawrence TS, Sarkaria JN, Wahl DR.

Neuro Oncol. 2019 May 23. pii: noz090. doi: 10.1093/neuonc/noz090. [Epub ahead of print]


Chemoprotective Effects of Dietary Grape Powder on UVB Radiation-Mediated Skin Carcinogenesis in SKH-1 Hairless Mice.

Singh CK, Mintie CA, Ndiaye MA, Chhabra G, Dakup PP, Ye T, Yu M, Ahmad N.

J Invest Dermatol. 2019 Mar;139(3):552-561. doi: 10.1016/j.jid.2018.09.028. Epub 2018 Oct 28.


Instrumental variable based estimation under the semiparametric accelerated failure time model.

Huling JD, Yu M, O'Malley AJ.

Biometrics. 2019 Jun;75(2):516-527. doi: 10.1111/biom.12985. Epub 2019 Mar 29.


On the effect of electronic patient portal on primary care utilization and appointment adherence.

Zhong X, Liang M, Sanchez R, Yu M, Budd PR, Sprague JL, Dewar MA.

BMC Med Inform Decis Mak. 2018 Oct 16;18(1):84. doi: 10.1186/s12911-018-0669-8.


HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients.

Burr AR, Harari PM, Ko HC, Chen S, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

Otorhinolaryngol Head Neck Surg. 2018;3(1). doi: 10.15761/OHNS.1000160. Epub 2018 Feb 24.


A robust approach to sample size calculation in cancer immunotherapy trials with delayed treatment effect.

Ye T, Yu M.

Biometrics. 2018 Dec;74(4):1292-1300. doi: 10.1111/biom.12916. Epub 2018 Jul 10.


A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).

Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC; Alliance ACS-CRP CCDR Breast Cancer Surveillance Working Group.

Ann Surg Oncol. 2018 Sep;25(9):2587-2595. doi: 10.1245/s10434-018-6496-4. Epub 2018 May 17.


The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients.

Esbona K, Yi Y, Saha S, Yu M, Van Doorn RR, Conklin MW, Graham DS, Wisinski KB, Ponik SM, Eliceiri KW, Wilke LG, Keely PJ.

Am J Pathol. 2018 Mar;188(3):559-573. doi: 10.1016/j.ajpath.2017.10.025.


Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01).

Neuman HB, Schumacher JR, Francescatti AB, Adesoye T, Edge SB, Vanness DJ, Yu M, McKellar D, Winchester DP, Greenberg CC; Alliance/American College of Surgeons Clinical Research Program Cancer Care Delivery Research Breast Cancer Surveillance Working Group.

J Clin Oncol. 2018 Apr 1;36(10):975-980. doi: 10.1200/JCO.2017.75.5389. Epub 2018 Jan 31.


A Computational-Based Approach to Identify Estrogen Receptor α/β Heterodimer Selective Ligands.

Coriano CG, Liu F, Sievers CK, Liang M, Wang Y, Lim Y, Yu M, Xu W.

Mol Pharmacol. 2018 Mar;93(3):197-207. doi: 10.1124/mol.117.108696. Epub 2018 Jan 2.


Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.

Galsky MD, Wang H, Hahn NM, Twardowski P, Pal SK, Albany C, Fleming MT, Starodub A, Hauke RJ, Yu M, Zhao Q, Sonpavde G, Donovan MJ, Patel VG, Sfakianos JP, Domingo-Domenech J, Oh WK, Akers N, Losic B, Gnjatic S, Schadt EE, Chen R, Kim-Schulze S, Bhardwaj N, Uzilov AV.

Eur Urol. 2018 May;73(5):751-759. doi: 10.1016/j.eururo.2017.12.001. Epub 2017 Dec 13.


Optimal treatment assignment to maximize expected outcome with multiple treatments.

Lou Z, Shao J, Yu M.

Biometrics. 2018 Jun;74(2):506-516. doi: 10.1111/biom.12811. Epub 2017 Oct 31.


Risk prediction for heterogeneous populations with application to hospital admission prediction.

Huling JD, Yu M, Liang M, Smith M.

Biometrics. 2018 Jun;74(2):557-565. doi: 10.1111/biom.12769. Epub 2017 Oct 26.


Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.

Ko HC, Harari PM, Chen S, Wieland AM, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1126-1133. doi: 10.1001/jamaoto.2017.1756.


A Statistical Framework for Pathway and Gene Identification from Integrative Analysis.

Li Q, Yu M, Wang S.

J Multivar Anal. 2017 Apr;156:1-17. doi: 10.1016/j.jmva.2016.12.005. Epub 2017 Jan 21.


Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Ko HC, Harari PM, Sacotte RM, Chen S, Wieland AM, Yu M, Baschnagel AM, Bruce JY, Kimple RJ, Witek ME.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350. doi: 10.1007/s00432-017-2481-8. Epub 2017 Jul 27.

Supplemental Content

Loading ...
Support Center